WINTON GROUP Ltd Sells 21,015 Shares of Calumet, Inc. $CLMT

WINTON GROUP Ltd lowered its holdings in Calumet, Inc. (NASDAQ:CLMT) by 31.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,085 shares of the oil and gas company’s stock after selling 21,015 shares during the period. WINTON GROUP Ltd’s holdings in Calumet were worth $896,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the business. Goldman Sachs Group Inc. grew its position in Calumet by 128.3% in the fourth quarter. Goldman Sachs Group Inc. now owns 348,115 shares of the oil and gas company’s stock valued at $6,917,000 after purchasing an additional 195,627 shares in the last quarter. BNP Paribas Financial Markets grew its position in Calumet by 3.4% in the fourth quarter. BNP Paribas Financial Markets now owns 290,729 shares of the oil and gas company’s stock valued at $5,777,000 after purchasing an additional 9,605 shares in the last quarter. Intech Investment Management LLC grew its position in Calumet by 10.3% in the fourth quarter. Intech Investment Management LLC now owns 21,957 shares of the oil and gas company’s stock valued at $436,000 after purchasing an additional 2,047 shares in the last quarter. Global Retirement Partners LLC bought a new position in Calumet in the fourth quarter valued at $34,000. Finally, Covestor Ltd grew its position in Calumet by 29.1% in the fourth quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock valued at $43,000 after purchasing an additional 492 shares in the last quarter. Institutional investors own 34.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on CLMT. Weiss Ratings raised shares of Calumet from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. HC Wainwright raised their target price on shares of Calumet from $33.00 to $60.00 and gave the company a “buy” rating in a research report on Monday, March 30th. UBS Group reaffirmed a “neutral” rating and issued a $26.00 target price on shares of Calumet in a research report on Friday, February 13th. TD Cowen restated a “hold” rating on shares of Calumet in a research note on Wednesday, June 3rd. Finally, The Goldman Sachs Group lowered shares of Calumet from a “buy” rating to a “neutral” rating and set a $36.00 price objective on the stock. in a research note on Friday, April 24th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $36.75.

Calumet Price Performance

Calumet stock opened at $34.05 on Wednesday. The firm has a market capitalization of $2.97 billion, a PE ratio of -15.76 and a beta of 0.73. The company’s 50-day moving average is $33.61 and its 200-day moving average is $27.07. Calumet, Inc. has a fifty-two week low of $12.94 and a fifty-two week high of $38.75.

Calumet (NASDAQ:CLMT) last announced its earnings results on Friday, May 8th. The oil and gas company reported ($3.64) EPS for the quarter, missing the consensus estimate of ($0.33) by ($3.31). The company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1 billion. The business’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period last year, the firm earned ($1.87) earnings per share. As a group, analysts expect that Calumet, Inc. will post -0.31 EPS for the current year.

Insider Activity

In related news, major shareholder Group Heritage sold 626,998 shares of Calumet stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $32.54, for a total transaction of $20,402,514.92. Following the completion of the sale, the insider owned 12,980,211 shares of the company’s stock, valued at approximately $422,376,065.94. The trade was a 4.61% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Daniel J. Sajkowski sold 3,310 shares of Calumet stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $34.46, for a total transaction of $114,062.60. Following the sale, the director directly owned 81,958 shares of the company’s stock, valued at $2,824,272.68. The trade was a 3.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 4.07% of the company’s stock.

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.